Objectives: To measure the variations amongst consultant gynaecologists all over the UK in managing women with postcoital bleeding (PCB).

Study Design: A questionnaire was sent to 1020 consultant gynaecologists in the UK, using the database of The Royal College of Obstetricians and Gynaecologists, enquiring about their opinions and the details of practice.

Results: Six hundred and fourteen (60%) replies were received. Three hundred and thirty-seven (59.8%) of the respondents agree that PCB is a significant clinical issue that requires developing national guidelines for management, 452 (80.1%) do not have local guidelines in their departments, 336 (59.6%) agree with The Department of Health guidelines for referral. Two hundred and eighty-one (49.8%) respondents see women in gynaecology clinic, 94 (16.7%) in colposcopy clinic, while 163 (28.9%) see them in either clinics depending on the workload. Only 275 (48.8%) respondents repeat the cervical smear for those with negative smear history who are still within the national screening interval. Chlamydia testing is performed by 450 (79.8%) respondents, whereas 68 (12.1%) consider investigating the endometrium in selected cases.

Conclusion: The results highlight the wide variations in managing women with PCB. Given the well-reported association with serious pathology, it may be prudent to standardise the management in the UK based on the best available evidence.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejogrb.2009.01.014DOI Listing

Publication Analysis

Top Keywords

postcoital bleeding
8
consultant gynaecologists
8
managing women
8
bleeding study
4
study current
4
current practice
4
practice consultants
4
consultants united
4
united kingdom
4
kingdom objectives
4

Similar Publications

Approach to cervical polyps in primary care.

Can Fam Physician

January 2025

Family medicine and emergency medicine physician practising in the South Shore region of Nova Scotia.

Objective: To provide primary care providers (PCPs) with an approach for diagnosing and managing endocervical polyps, detailing a procedural technique for cervical polypectomy and outlining key information on when to refer to a gynecologist.

Sources Of Information: This review and approach are based on the second author's clinical practice and available literature from 1994 to 2023.

Main Message: Cervical polyps are commonly asymptomatic and benign, but can cause intermenstrual and postcoital bleeding.

View Article and Find Full Text PDF

Prolapsed fallopian tube to the vagina after hysterectomy a year ago: A case report.

Taiwan J Obstet Gynecol

January 2025

Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 40203, Taiwan; Institute of Medicine, Chung Shan Medical University, Taichung 40203, Taiwan.

Objective: This case report aims to present a rare occurrence of fallopian tube prolapse into the vaginal vault following hysterectomy, underscoring the importance of recognizing this uncommon complication.

Case Report: A 45-year-old woman, with a history of hysterectomy for adenomyosis, presented with symptoms mimicking a vaginal tumor, including persistent discharge, abdominal pain, postcoital bleeding, and weight loss. Imaging raised concerns of malignancy, but surgery revealed a prolapsed fallopian tube with chronic inflammation.

View Article and Find Full Text PDF

Neuroendocrine carcinoma of the cervix (NECC) is a rare and extremely aggressive disease. Treatment options are scarce (mainly consisting of platinum-based chemotherapy combinations), and randomized controlled trials are lacking, leading to a very poor prognosis. It is prone to early metastasis, often with more than one affected site at diagnosis.

View Article and Find Full Text PDF

Promising selective progesterone receptor modulators: what's new in female contraception?

Expert Opin Investig Drugs

December 2024

Department of Obstetrics and Gynecology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

Introduction: Selective progesterone receptor modulators (SPRMs), such as mifepristone and ulipristal acetate (UPA), have demonstrated high efficacy and safety as single-dose treatments for medication abortion and emergency contraception (EC). Other obstetrical and gynecologic applications have emerged, both for episodic and ongoing uses. The potential of these compounds to provide estrogen-free, ongoing contraception is promising; however, the rare, but serious, hepatic injury cases seen with UPA have put at least a temporary halt to further research in this area.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!